Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
6.06
+0.07 (1.17%)
Sep 30, 2026, 4:08 PM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 4.75 billion as of October 1, 2026. Its market cap has decreased by -38.71% in one year.
Market Cap
4.75B
Enterprise Value
2.99B
Revenue
852.85M
Ranking
n/a
PE Ratio
7.91
Stock Price
6.06
ChartMarket Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 4.75B, a decrease of -56.68%. That is a compound annual growth rate of -13.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.75B | -5.35% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CARsgen Therapeutics Holdings | 7.00B |
| Shaanxi Micot Pharmaceutical Technology | 6.85B |
| TenNor Therapeutics (Suzhou) | 6.08B |
| Abbisko Cayman | 5.78B |
| CK Life Sciences Int'l., (Holdings) | 5.14B |
| TransThera Sciences (Nanjing) | 4.12B |
| Ocumension Therapeutics | 4.11B |
| Shanghai Bao Pharmaceuticals | 4.02B |